Feasibility Study and Preliminary Application Study on Iris OCTA
Feasibility Study and Preliminary Application Study on Noninvasive Iris Optical Coherence Tomography Angiography (OCTA)
Sponsor: Shanghai Eye Disease Prevention and Treatment Center
A observational or N/A phase clinical study on Conjunctivitis and Diabetic Retinopathy, this trial is ongoing. The trial is conducted by Shanghai Eye Disease Prevention and Treatment Center and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Oct 2020 — Jan 2021 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Oct 2018 — Oct 2020 [monthly]
Not Yet Recruiting
▶ Show 1 earlier version
-
Sep 2018 — Oct 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Shanghai Eye Disease Prevention and Treatment Center
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.